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Leukemia is the most common cancer in 
children worldwide (0–14 years of age), with 
more than 2,600 cases diagnosed annually in 
the United States (Ferlay et al. 2004; Parkin 
et al. 2005). The main two histological groups 
are acute lymphoblastic leukemia (ALL) and 
acute myeloid leukemia (AML), represent-
ing 80% and 13% of all cases in the United 
States, respectively (Parkin et al. 2005). 
Recently, greater heterogeneity of childhood 
leukemias has been recognized, and they have 
been subclassified according to their cyto-
genetics. The causes of childhood leukemia 
remain largely unknown, and recognized 
risk factors, such as genetic conditions (e.g., 
Down syndrome), ionizing radiation, and 
chemotherapeutic agents, explain only a small 
proportion of cases (Buffler et al. 2005).
Exposures to paint and solvents have been 
suggested as potential risk factors of childhood 
leukemia. Paint is a generic name for a number 
of different products, and its potential toxic-
ity depends on the types of pigments, resins, 
and solvents used in its manufacture (Kirk-
Othmer 2006). One of the two major groups 
of paints is latex paints, for which the resin is 
acrylic-, vinyl-, or styrene-based and the sol-
vent is water, with the customary addition of 
glycol ethers and coalescent aid that helps the 
resins flow together, aiding in film formation. 
The other is the alkyd paints or oil-based resin 
paints, in which the solvent is usually petro-
leum-based and organic, such as toluene or 
xylene. Similarly, petroleum solvents encom-
pass a wide variety of materials derived from 
crude oil [International Agency for Research on 
Cancer (IARC) Monograph Working Group 
1989], including many that are widely used in 
the home, such as paint thinner, spot remover, 
gasoline, kerosene, and lubricating oil.
Most previous epidemiologic studies have 
examined the impact of paint and solvents on 
the risk of childhood leukemia through parental 
occupational exposures and have reported con-
flicting results (Colt and Blair 1998; Feychting 
et al. 2001; Infante-Rivard et al. 2005; 
McKinney et al. 2003; Schüz et al. 2000; Shu 
et al. 1999). Only four studies described results 
for home use of these products (Alderton et al. 
2006; Freedman et al. 2001; Infante-Rivard 
et al. 2005; Lowengart et al. 1987), with two 
reporting a suggestive association with paint 
exposure (Freedman et al. 2001; Lowengart 
et al. 1987). Inconsistencies among the previ-
ous findings may be attributable to hetero-
geneous time windows of exposures, multiple 
sources of exposures, and heterogeneous types 
of   leukemia analyzed together.
Our objective was to determine whether 
an association exists between the risk of 
childhood leukemia and household expo-
sure to paint and/or petroleum solvents, 
during different time windows of exposure 
(pre  conception, pregnancy, and early child-
hood), for ALL and AML separately, and by 
major cytogenetic subtype. We based analy-
ses on data from the Northern California 
Childhood Leukemia Study (NCCLS), a 
large population-based case–control study 
that covers 35 California counties.
Material and Methods
The study was approved by the University of 
California Committee for the Protection of 
Human Subjects, the California Health and 
Human Services Agency Committee for the 
Protection of Human Subjects, and the insti-
tutional review boards of the nine participat-
ing hospitals. We obtained written informed 
consent from the parents of all participating 
subjects before interviews.
Study population. The NCCLS is an 
ongoing, population-based case–control 
study that began in 1995. The present analy-
sis used data from two phases: cases diag-
nosed from 31 August 1995 to 30 November 
1999 in 17 counties in the San Francisco 
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ba c K g R O u n d: Few studies have examined the association between home use of solvents and paint 
and the risk of childhood leukemia.
Objectives: In this case–control study, we examined whether the use of paint and petroleum sol-
vents at home before birth and in early childhood influenced the risk of leukemia in children.
Me t h O d s : We based our analyses on 550 cases of acute lymphoblastic leukemia (ALL), 100 cases 
of acute myeloid leukemia (AML), and one or two controls per case individually matched for sex, 
age, Hispanic status, and race. We conducted further analyses by cytogenetic subtype. We used 
conditional logistic regression techniques to adjust for income.
Re s u l t s: ALL risk was significantly associated with paint exposure [odds ratio (OR) = 1.65; 95% 
confidence interval (CI), 1.26–2.15], with a higher risk observed when paint was used postnatally, 
by a person other than the mother, or frequently. The association was restricted to leukemia with 
translocations between chromosomes 12 and 21 (OR = 4.16; 95% CI, 1.66–10.4). We found no 
significant association between solvent use and ALL risk overall (OR = 1.15; 95% CI, 0.87–1.51) 
or for various cytogenetic subtypes, but we observed a significant association in the 2.0- to 5.9-year 
age group (OR = 1.55; 95% CI, 1.07–2.25). In contrast, a significant increased risk for AML was 
associated with solvent (OR = 2.54; 95% CI, 1.19–5.42) but not with paint exposure (OR = 0.64; 
95% CI, 0.32–1.25).
cO n c l u s i O n s: The association of ALL risk with paint exposure was strong, consistent with a causal 
relationship, but further studies are needed to confirm the association of ALL and AML risk with 
solvent exposure.
Key w O R d s : case–control study, children, leukemia, paint, petroleum, solvents. Environ Health 
Perspect 117:133–139 (2009).  doi:10.1289/ehp.11927 available via http://dx.doi.org/ [Online 
10 October 2008]Scélo et al.
134  v o l u m e  117 | n u m b e r 1 | January 2009  •  Environmental Health Perspectives
Bay Area (phase 1), and cases diagnosed from 
1 December 1999 to 6 December 2005 in 
the same area and an additional 18 coun-
ties in California Central Valley (phase 2). 
We identified incident cases on the basis 
of International Classification of Diseases for 
Oncology (Fritz et al. 2000; Percy et al. 1990) 
using rapid case ascertainment procedure in 
four (phase 1) to nine (phase 2) pediatric 
hospitals, usually within 72 hr after diag-
nosis. Cases were eligible if they were < 15 
years of age at diagnosis, had no prior cancer 
diagnosis, lived in the study area, and their 
biological parents spoke either English or 
Spanish. Comparison of case ascertainment 
in the 35-county study area to the California 
Cancer Registry data (1997–2003; http://
www.ccrcal.org/) showed that the NCCLS 
ascertained 96% of children diagnosed with 
leukemia in the four phase 1 participating 
hospitals, and 93% in the nine phase 2 hos-
pitals. Overall, the cases diagnosed at the par-
ticipating hospitals and ascertained through 
the NCCLS protocol represent approxi-
mately 76% of the diagnosed cases in the 
35 study counties. Of the eligible cases, 86% 
consented to participate.
We randomly selected one or two con-
trol children who resided within the study 
area from birth certificates supplied by the 
California Department of Health Services 
(Sacramento, CA) and individually matched 
them to cases on date of birth, sex, Hispanic 
ethnicity (we considered a child Hispanic if 
either parent was Hispanic), and maternal 
race. Contact failed for 13% selected controls; 
we then randomly selected another matched 
control. Of the controls that we located, the 
participation rate, defined as the number of 
participating controls divided by the number 
of eligible or presumed eligible controls, was 
68%. Further description of NCCLS control 
recruitment has been previously published 
(Kwan et al. 2007; Ma et al. 2004).
Since 1995, data for 669 case–control 
sets have been accumulated, with a total of 
1,558 children. For the present analyses, 
we included only ALL and AML cases. In 
addition, we excluded case–control sets with 
missing data for exposure to paint or solvent 
for cases or controls from the analyses, result-
ing in 650 case–control sets (438 pairs and 
212 triplets) with 550 case–control sets for 
ALL analyses and 100 case–control sets for 
AML. Table 1 presents selected characteris-
tics of the participating children.
Cytogenetic classification. Methods used 
by the NCCLS to assess cytogenetic abnor-
malities in leukemic cells have been previously 
described (Aldrich et al. 2006). Briefly, hospi-
tals released medical record abstracts of par-
ticipating cases that contained conventional 
banding karyotypes and occasional fluores-
cence in situ hybridization (FISH) screening. 
We conducted additional FISH analyses for 
ambiguous cases. We classified diagnostic 
karyotypes according to clonal genetic aber-
ration using the International System for 
Human Cytogenetic Nomenclature 1995 cri-
teria (Mitelman 1995). To date, cytogenetic 
information is available for 76% of ALL and 
83% of AML cases included in the present 
study. We conducted analyses for major sub-
groups: for ALL, translocation between chro-
mosomes 12 and 21 [t(12;21)], chromosomal 
deletions, hypodiploidy, and hyperploidy 
including low hyperdiploidy (47–50 chromo-
somes), high hyperdiploidy (51–68 chromo-
somes), and triploidy (69 chromosomes); for 
AML, we conducted analyses separately for 
the more favorable prognosis group, which 
encompasses any translocation involving 
chromosome 21, between chromosomes 15 
and 17 t(15;17), and between chromosomes 8 
and 16 t(8;16) and inversion on chromosome 
16 [inv(16)], and for cases with any numerical 
change (Deschler and Lübbert 2006).
Exposure assessment. We assessed house-
hold exposures to paint and petroleum sol-
vents through an in-home personal interview 
conducted with the child’s biological mother 
(98% of interviews) or father (2%), which 
in addition to exposure to paint and petro-
leum solvents also included other chemical 
and pesticide exposures at home, occupational 
history, residential history, smoking habits, 
mother’s pregnancy and child’s delivery, 
mother’s reproductive history, child’s health/
medical history, family illness, and mother’s 
and child’s diets. We asked parents whether 
Table 1. Selected characteristics of participating cases and controls [n (%)] by leukemia histological type: 
NCCLS.
  ALL  AML
Characteristic  Cases  Controls  Cases  Controls
Total  550  737  100  125
Sex
  Male  311 (56.5)  415 (56.3)  55 (55.0)  68 (54.4)
  Female  239 (43.5)  322 (43.7)  45 (45.0)  57 (45.6)
Age at reference datea (years)
  0.0–1.9  62 (11.3)  80 (10.9)  30 (30.0)  37 (29.6)
  2.0–5.9  313 (56.9)  425 (57.7)  20 (20.0)  28 (22.4)
  6.0–14.9  175 (31.8)  232 (31.5)  50 (50.0)  60 (48.0)
  Median (interquartile range)  4.5 (2.8–7.2)  4.4 (2.8–7.0)  6.1 (1.7–10.7)  5.8 (1.8–9.5)
Phase of the study
  Phase 1b  156 (28.4)  156 (21.2)  38 (38.0)  38 (30.4)
  Phase 2c  394 (71.6)  581 (78.8)  62 (62.0)  87 (69.6)
Ethnicity
  Hispanic  247 (44.9)  320 (43.4)  39 (39.0)  49 (39.2)
  Non-Hispanic white  221 (40.2)  303 (41.1)  40 (40.0)  55 (44.0)
  Non-Hispanic other  82 (14.9)  114 (15.5)  21 (21.0)  21 (16.8)
Household income (US$ 1,000/year)
  < 15  87 (15.8)  76 (10.3)  21 (21.0)  11 (8.8)
  15–29  98 (17.8)  105 (14.2)  17 (17.0)  17 (13.6)
  30–44  84 (15.3)  95 (12.9)  16 (16.0)  15 (12.0)
  45–59  89 (16.2)  100 (13.6)  10 (10.0)  20 (16.0)
  60–74  48 (8.7)  80 (10.9)  12 (12.0)  14 (11.2)
  ≥ 75  144 (26.2)  281 (38.1)  24 (24.0)  48 (38.4)
Father’s education level
  None or elementary school  56 (10.2)  79 (10.7)  11 (11.0)  12 (9.6)
  High school or similar  196 (35.6)  224 (30.4)  36 (36.0)  43 (34.4)
  Some college or similar  116 (21.1)  188 (25.5)  18 (18.0)  29 (23.2)
  Bachelors degree or higher  163 (29.6)  216 (29.3)  32 (32.0)  40 (32.0)
  Missing  19 (3.5)  30 (4.1)  3 (3.0)  1 (0.8)
Mother’s education level
  None or elementary school  69 (12.5)  58 (7.9)  13 (13.0)  11 (8.8)
  High school or similar  168 (30.5)  210 (28.5)  30 (30.0)  35 (28.0)
  Some college or similar  159 (28.9)  239 (32.4)  24 (24.0)  33 (26.4)
  Bachelors degree or higher  154 (28.0)  229 (31.1)  33 (33.0)  46 (36.8)
  Missing  0 (0.0)  1 (0.1)  0 (0.0)  0 (0.0)
Father’s age at child’s birth (years)
  Median (interquartile range)  31.0 (25.7–35.6)  31.2 (26.5–35.8)  29.6 (25.5–34.9)  32.4 (26.0–35.5)
  Mean ± SD  30.9 ± 7.1  31.4 ± 7.0  30.8 ± 7.2  31.5 ± 6.6
Mother’s age at child’s birth (years)
  Median (interquartile range)  28.8 (23.5–32.9)  28.8 (24.2–33.5)  27.7 (23.2–31.6)  29.6 (25.5–33.2)
  Mean ± SD  28.4 ± 6.1  29.0 ± 6.1  27.9 ± 6.4  29.4 ± 6.0
aReference date was defined as the date of diagnosis for cases and corresponding date for matched controls. bAu-
gust 1995 through November 1999, covering 17 counties: Alameda, Contra Costa, Marin, Merced, Monterey, Napa, 
Sacramento, San Benito, San Francisco, San Joaquin, San Mateo, Santa Clara, Santa Cruz, Solano, Sonoma, Stanislaus, 
and Yolo. cDecember 1999 through December 2005, covering 35 counties: 17 counties from phase 1, plus Amador, Butte, 
Calaveras, Colusa, El Dorado, Fresno, Glenn, Kern, Kings, Madera, Mariposa, Nevada, Placer, San Luis Obispo, Sutter, 
Tulare, Tuolumne, and Yuba.Paint, solvents, and the risk of childhood leukemia
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“paints, stains, or lacquers” (which we refer to 
as paint) and “adhesives or petroleum prod-
ucts, such as paint thinner, spot remover, 
paint remover, glue, solvent, gasoline, kero-
sene, or lubricating oil” (which we refer to as 
solvents) were ever used in their house within 
seven time windows (3 months before the 
pregnancy, during the first, the second, or the 
third trimester of the pregnancy, and from 
birth to 1 year of age, from 1 to 2 years of age, 
or from 2 to 3 years of age). We defined the 
reference date as the date of diagnosis for cases 
and corresponding date for matched controls. 
For children recruited until 2002, we censored 
exposures at the time window preceding the 
reference date (e.g., from birth to 1 year if the 
case was diagnosed between 1 and 2 years of 
age). Censoring exposures at the preceding 
time window was no longer necessary from 
2003 onward because we changed the ques-
tionnaire to avoid possible recording of expo-
sures that occurred after the reference date. We 
further detailed exposures to paint and solvents 
by user (mother, father, others) and frequency 
of use (fewer than five times, or five times or 
more) in the corresponding time window.
Exposure prevalence and patterns. 
Overall, paint and petroleum solvents were 
used in households of 56% and 42% of cases, 
respectively, and 50% and 35% of control 
households. Table 2 further describes expo-
sure patterns, by person who used the prod-
uct, and by period when the product was 
used. For ALL or AML cases and controls 
and for both paint and solvent exposures, 
the father was the most frequent user and 
use was less common during pregnancy than 
after birth. Generally, households reported 
using paint less often than solvents in terms 
of median number of time windows when 
the product was used (one for paint vs. four 
for solvents) and frequency of use within 
each time window (25% had frequent use for 
paint vs. 47% for solvents).
Statistical analyses. We conducted analyses 
separately for ALL and AML and by major 
cytogenetic subtypes, because evidence is 
increasing that these subtypes may differ in 
terms of risk factors. We calculated Spearman’s 
rank correlation coefficients between various 
time windows of exposure and highly corre-
lated variables—that is, correlation coefficients 
> 0.80 were combined into one variable; this 
was the case only for use of solvent during the 
preconception and pregnancy periods com-
bined into prenatal period. We used condi-
tional logistic regression models to estimate the 
odds ratios (ORs) associated with home use 
of paint and solvents. These models employed 
binary variables for use of paint and/or sol-
vents during the period of interest plus a series 
of potential confounders (household annual 
income, mother’s education level, father’s edu-
cation level, breast-feeding, parental smoking, 
parental occupational exposure to paint and/or 
solvents, and parents’ age at child’s birth). We 
assessed the influences of these variables with 
likelihood ratio chi-square tests. Only income 
(ordinal variable) and father’s education level 
significantly improved the likelihood of the 
models (data not shown). However, because 
including the father’s education level in the 
models modified the estimates of the OR by 
< 2% (compared with ≥ 10% for income), we 
present only results adjusted for income. To 
investigate the role of the time window when 
the product was used, we included binary vari-
ables coding for use during preconception, dur-
ing pregnancy, and postnatally in the model 
together and used likelihood methods to test 
their statistical significance. We tested whether 
the user (mother, father, others) affected the 
model’s likelihood using the same method. 
We tested interaction between matching fac-
tors [i.e., sex, age at diagnosis (reference) date, 
Hispanic status, and mother’s race] and paint 
and solvent exposure by including the interac-
tion term in the regression models. For this 
purpose, we chose age categories (0–1.9, 2–5.9, 
6–14.9 years of age) to fit the age-specific inci-
dence curve of leukemia in childhood. 
We created two categorical quantitative 
indexes for frequency of use separately for 
paint and solvents, taking into account the 
number of time windows when the prod-
uct was used (median served as the threshold 
between categories) and the frequency dur-
ing each time window: We considered use 
of paint rare if used only during one time 
window and fewer than five times, and fre-
quent otherwise (i.e., more than five times 
in one time window or in two or more time 
windows); we considered use of solvents rare 
if used in four or fewer time windows and 
fewer than five times in each time window, 
and frequent otherwise (i.e., more than five 
times in one time window or in five or more 
time windows). 
We calculated p-values for linear trend 
(ptrend) when risk estimates showed a pattern 
consistent with a linear dose–response rela-
tionship. All statistical tests were two sided 
with α = 0.05.
Results
Exposures to paint and petroleum solvents were 
not independent from each other [Spearman 
correlation coefficient (r) = 0.39, p < 0.001]. 
Proportions of households that used paint only, 
petroleum solvents only, and both were 23%, 
9%, and 29%, respectively. The correlation 
array of detailed exposures by time windows 
(preconception, pregnancy, postnatal) showed 
low to moderate correlations (r ranged from 
0.16 to 0.64), except for petroleum solvent 
exposure during preconception period and 
pregnancy (r = 0.80, p < 0.001). We combined 
these exposures into one “prenatal exposure” 
variable for the subsequent analyses. Household 
annual income was positively correlated with 
use of paint (r = 0.22, p < 0.001) and solvents 
(r = 0.23, p < 0.001).
Table 2. Characteristics of paint and petroleum solvent use in households of children participating in the 
NCCLS [n (%)].
  ALL   AML
  Cases  Controls  Cases  Controls
User and time window of use  (n = 550)  (n = 737)  (n = 100)  (n = 125)
Paint
  Overall  322 (58.5)  366 (49.7)  44 (44.0)  61 (48.8)
  By mother  172 (31.3)  206 (28.0)  24 (24.0)  32 (25.6)
  By father  203 (36.9)  229 (31.1)  22 (22.0)  37 (29.6)
  By another person  105 (19.1)  95 (12.9)  14 (14.0)  14 (11.2)
  During the 3 months before pregnancy  54 (9.8)  61 (8.3)  12 (12.0)  9 (7.2)
  During first trimester  51 (9.3)  46 (6.2)  11 (11.0)  8 (6.4)
  During second trimester  53 (9.6)  54 (7.3)  12 (12.0)  10 (8.0)
  During third trimester  84 (15.3)  95 (12.9)  16 (16.0)  17 (13.6)
  From birth to first birthday/reference datea  115 (21.4)  134 (18.5)  19 (20.9)  21 (17.5)
  From first birthday to second birthday/reference dateb  126 (24.9)  151 (22.0)  20 (25.6)  22 (21.8)
  From second birthday to third birthday/reference datec  120 (28.0)  153 (25.8)  16 (24.6)  20 (23.5)
Petroleum solvents
  Overall  230 (41.8)  270 (36.6)  40 (40.0)  35 (28.0)
  By mother  102 (18.5)  128 (17.4)  16 (16.0)  15 (12.0)
  By father  158 (28.7)  177 (24.0)  31 (31.0)  28 (22.4)
  By another person  41 (7.5)  39 (5.3)  5 (5.0)  5 (4.0)
  During the 3 months before pregnancy  113 (20.5)  132 (17.9)  17 (17.0)  21 (16.8)
  During first trimester  110 (20.0)  135 (18.3)  17 (17.0)  21 (16.8)
  During second trimester  112 (20.4)  142 (19.3)  19 (19.0)  22 (17.6)
  During third trimester  120 (21.8)  144 (19.5)  21 (21.0)  21 (16.8)
  From birth to first birthday/reference datea  139 (25.8)  172 (23.8)  20 (22.0)  24 (20.0)
  From first birthday to second birthday/reference dateb  144 (28.5)  170 (24.8)  22 (28.2)  24 (23.8)
  From second birthday to third birthday/reference datec  132 (30.8)  155 (26.1)  19 (29.2)  20 (23.5)
aDenominators = 538 for ALL cases, 724 for ALL controls, 91 for AML cases, and 120 for AML controls. bDenominators = 
506 for ALL cases, 685 for ALL controls, 78 for AML cases, and 101 for AML controls. cDenominators = 428 for ALL cases, 
593 for ALL controls, 65 for AML cases, and 85 for AML controls.Scélo et al.
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ALL. In univariate analyses, ORs were 
1.49 [95% confidence interval (CI), 1.18–
1.89] for paint exposure and 1.24 (95% CI, 
0.97–1.59) for solvent exposure. After adjust-
ment for income, they were 1.73 (95% CI, 
1.35–2.21) and 1.39 (95% CI, 1.08–1.79), 
respectively. When we included both expo-
sures in the model, OR for paint was 1.65 
(95% CI, 1.26–2.15) and OR for solvent was 
1.15 (95% CI, 0.87–1.51). We detected no 
significant interaction between the two expo-
sures (p = 0.187). When we calculated risk 
estimates with a mutually exclusive categorical 
variable using nonusers of paint or solvents as 
the reference category, paint users had an OR 
of 1.84 (95% CI, 1.34–2.53), solvent users 
had an OR of 1.47 (95% CI, 0.93–2.32), 
and both exposures together produced an OR 
of 1.86 (95% CI, 1.37–2.53). We found no 
differences in ORs by child’s Hispanic sta-
tus or sex or mother’s race, whereas the risk 
of childhood ALL somewhat varied by age 
category for exposure to solvents (p for het-
erogeneity = 0.077) but not paint (p = 0.359). 
Table 3 shows results for various users and 
time windows of exposures, stratified by age 
at diagnosis. Overall, the increased risk asso-
ciated with paint exposure was statistically 
significant in the two youngest age categories 
(0- to 1.9-year-olds: OR = 2.70; 95% CI, 
1.14–6.42; 2.0- to 5.9-year-olds: OR = 1.72; 
95% CI, 1.21–2.45) but not in children diag-
nosed at ≥ 6 years of age (OR = 1.36; 95% 
CI, 0.84–2.20). We observed the increased 
risk associated with paint exposure when used 
by the father or others after birth. This obser-
vation was also true in the 2- to 5.9-year age 
category. On the contrary, ORs in the 0- to 
1.9-year age category were higher when paint 
was used by the mother and before birth, 
although this finding was not statistically sig-
nificant. There was a significant increased risk 
of ALL associated with solvent exposure in 
the 2- to 5.9-year age category (OR = 1.55; 
95% CI, 1.07–2.25), but not in younger (OR 
= 0.66; 95% CI, 0.30–1.47) or in older chil-
dren (OR = 0.87; 95% CI, 0.54–1.42).
Children of frequent users of paint had 
higher risk of ALL (OR = 1.74; 95% CI, 
1.25–2.43) than did rare users (OR = 1.28; 
95% CI, 0.92–1.78), with a statistically sig-
nificant linear trend (p = 0.001). We found 
this dose–response relationship in both the 0- 
to 1.9-year age category (p = 0.031) and the 
2.0- to 5.9-year age category (p = 0.010).
When the analyses were restricted to spe-
cific cytogenetic subtypes, paint exposure was 
associated with a significant increased risk of 
ALL with chromosomal structural changes, 
specifically with t(12;21) (Table 4). Among 
cases with t(12;21), ORs for preconception, 
pregnancy, and postnatal exposure to paint 
were 0.43 (95% CI, 0.11–1.64), 3.28 (95% 
CI, 1.12–9.60), and 4.15 (95% CI, 1.61–
10.7), respectively. Concerning ALL cases 
with numerical chromosome changes in leu-
kemic cells, the association with paint expo-
sure was of borderline statistical significance 
(p = 0.056). We found no statistical signifi-
cant results in relation to solvent exposure.
AML. In univariate analyses, ORs were 
0.83 (95% CI, 0.48–1.45) for paint exposure 
and 1.89 (95% CI, 1.00–3.49) for solvent 
exposure. After adjustment for income, the 
estimated ORs were 0.91 (95% CI, 0.51–
1.63) and 2.05 (95% CI, 1.05–4.01), respec-
tively. When we included both exposures in 
the model, the OR for paint was 0.64 (95% 
CI, 0.32–1.25) and for solvents was 2.54 
(95% CI, 1.19–5.42) (Table 5). We detected 
no significant interaction between the two 
exposures (p = 0.270). We found no differ-
ences in risk estimates by Hispanic status, 
sex, age at diagnosis, or mother’s race. Table 
5 presents detailed results by time window of 
use, type of user, and frequency. When ana-
lyzing the frequency of solvent use, the OR 
among rare users (n = 15) was higher than 
among frequent users (n = 35). Although 
based on small numbers, analyses by main 
Table 3. ORs (95% CIs) of ALL for household use of paint and solvents for various users and time windows of use, stratified by age at diagnosis (conditional logis-
tic regressions, adjustment for income and either paint or solvent exposure).
  Age at diagnosis (years)
  All cases (n = 550)  0–1.9 (n = 62)  2.0–5.9 (n = 313)  6.0–14.9 (n = 175)
  No. of discordant    No. of discordant    No. of discordant    No. of discordant
Exposure  pairs/triplets (%)  OR (95% CI)  pairs/triplets (%)  OR (95% CI)  pairs/triplets (%)  OR (95% CI)  pairs/triplets (%)  OR (95% CI)
Paint
  Overall  302 (54.9)  1.65 (1.26–2.15)  31 (50.0)  2.70 (1.14–6.42)  181 (57.8)  1.72 (1.21–2.45)  90 (51.4)  1.36 (0.84–2.20)
  By period of exposure
  Preconception  106 (19.3)  1.10 (0.71–1.69)  10 (16.0)  2.91 (0.48–17.6)  55 (17.6)  1.04 (0.58–1.87)  41 (23.4)  1.08 (0.53–2.24)
  Pregnancy  196 (35.6)  1.21 (0.88–1.67)  27 (43.5)  1.92 (0.69–5.39)  107 (34.2)  1.21 (0.78–1.88)  62 (35.4)  1.12 (0.62–2.02)
  After birth  292 (53.1)  1.39 (1.07–1.81)  25 (40.3)  1.11 (0.45–2.76)  176 (56.2)  1.46 (1.13–2.38)  91 (52.0)  1.35 (0.84–2.17)
  By user     
  Mother  252 (45.8)  1.19 (0.89–1.58)  24 (38.7)  2.49 (0.92–6.78)  155 (49.5)  1.20 (0.83–1.75)  73 (41.7)  1.06 (0.61–1.84)
  Father  281 (51.1)  1.44 (1.08–1.91)  27 (43.5)  2.06 (0.80–5.27)  170 (54.3)  1.50 (1.04–2.17)  84 (48.0)  1.29 (0.76–2.19)
  Others  166 (30.2)  1.63 (1.17–2.26)  14 (22.6)  0.83 (0.24–2.84)  95 (30.6)  1.85 (1.17–2.93)  57 (32.6)  1.45 (0.85–2.49)
  Frequency of usea    
  Rarely  154 (28.0)  1.28 (0.92–1.78)  21 (33.9)  2.36 (0.89–6.29)  95 (30.4)  1.40 (0.90–2.17)  38 (21.7)  0.83 (0.44–1.59)
  Frequently  194 (35.3)  1.74 (1.25–2.43)  15 (24.2)  3.50 (1.08–11.4)  115 (36.7)  1.77 (1.13–2.75)  64 (36.6)  1.48 (0.83–2.62)
  ptrend
b    0.001    0.031    0.010    —
Solvents
  Overall  271 (49.3)  1.15 (0.87–1.51)  32 (51.6)  0.66 (0.30–1.47)  150 (47.9)  1.55 (1.07–2.25)  89 (50.9)  0.87 (0.54–1.42)
  By period of exposure
  Before birth  214 (38.9)  1.19 (0.83–1.71)  28 (45.2)  1.49 (0.49–4.49)  121 (38.7)  1.20 (0.74–1.95)  65 (37.1)  1.13 (0.60–2.14)
  After birth  245 (44.5)  1.06 (0.76–1.50)  21 (33.9)  0.60 (0.19–1.87)  145 (46.3)  1.26 (0.80–1.98)  79 (45.1)  0.93 (0.50–1.72)
  By user   
  Mother  161 (29.3)  1.08 (0.77–1.51)  17 (27.4)  1.00 (0.36–2.78)  101 (32.3)  1.41 (0.91–2.20)  43 (24.6)  0.70 (0.36–1.38)
  Father  237 (43.1)  1.17 (0.88–1.56)  29 (46.8)  0.66 (0.27–1.57)  137 (43.8)  1.44 (0.98–2.11)  71 (40.6)  1.06 (0.63–1.78)
  Others  79 (14.4)  1.16 (0.73–1.86)  8 (12.9)  2.66 (0.60–11.8)  40 (12.8)  1.10 (0.56–2.17)  31 (17.7)  1.15 (0.52–2.52)
  Frequency of usec 
  Rarely  109 (19.8)  1.12 (0.75–1.67)  14 (22.6)  0.42 (0.12–1.40)  62 (19.8)  1.78 (1.04–3.04)  33 (18.9)  0.59 (0.26–1.33)
  Frequently  180 (32.7)  1.31 (0.95–1.81)  20 (32.3)  1.06 (0.41–2.75)  99 (31.6)  1.50 (0.96–2.34)  61 (34.9)  1.22 (0.70–2.13)
  ptrend
b    0.102    —    —    —
a“Rarely” indicates one time window only (preconception, first, second, and third trimester of pregnancy, first, second, and third year of life) and fewer than five times; “Frequently” 
indicates other combinations. bp-Value obtained when entered as a continuous variable in the model (calculated only when risk estimates showed a pattern consistent with a linear 
dose–response relationship). c“Rarely” indicates four time windows or fewer (preconception, first, second, and third trimester of pregnancy, first, second, and third year of life), and 
fewer than five times in each; “Frequently” indicates other combinations.Paint, solvents, and the risk of childhood leukemia
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cytogenetic subgroup (Table 6) showed ele-
vated nonsignificant ORs for solvent exposure 
and AML cases with any structural change 
(OR = 2.50; 95% CI, 0.96–6.54), more spe-
cifically in the favorable prognosis group (OR 
= 3.49; 95% CI, 0.92–13.2), whereas we saw 
no association for AML with no detectable 
chromosome abnormalities.
Discussion
In a large population-based case–control 
study that collected detailed self-reported 
home use of paint and solvents, our analyses 
identified a statistically significant associa-
tion between paint exposure and ALL risk in 
childhood (OR = 1.65; 95% CI, 1.26–2.15), 
which was stronger in frequent users (OR = 
1.74; 95% CI, 1.25–2.43) compared with 
rare users (OR = 1.28; 95% CI, 0.92–1.78) 
(ptrend = 0.001). Associations between ALL 
risk and solvent exposures were less consis-
tent. In contrast, AML risk was significantly 
associated with solvent exposure (OR = 2.54; 
95% CI, 1.19–5.42) but not with paint use 
(OR = 0.64; 95% CI, 0.32–1.25).
To our knowledge, no previous study has 
reported results of risks associated with paint 
and solvent exposures by cytogenetic sub-
group of childhood leukemia. Yet this form 
of analysis may provide mechanistic explana-
tions of the epidemiologic findings (Wiemels 
2008). Although we observed no difference in 
risk estimates for the association between sol-
vent exposure and ALL risk, our analyses have 
shown that association between paint expo-
sure and ALL risk was statistically significant 
for cases with chromosomal structural changes 
in leukemic cells (OR = 1.96; 95% CI, 1.24–
3.10) but of borderline significance for those 
with numerical changes (OR = 1.48; 95% 
CI, 0.99–2.21). Paint exposures appeared to 
be specifically related to ALL with t(12;21), 
but we are not sure whether they influence 
the identified genetic “hits” or influence the 
progression of the disease via other means, 
for instance, epigenetic changes or nongeno-
toxic bone marrow suppression followed by 
regrowth (Wiemels et al. 2008). Indeed, our 
results showed that both pre- and postnatal 
exposures to paints conferred increased risk 
of ALL with t(12;21), hence supporting that 
timing of cell damages is unlikely to occur 
only in utero. Despite recent advances in 
the understanding of biological mechanisms 
leading to leukemia development, it is not 
known what factors might cause transloca-
tions to occur in utero (McHale and Smith 
2004). How environmental exposures may 
modulate the progression of the preleuke-
mic clones to leukemia is also unknown. 
The specificity of the association with paint 
toward t(12;21) over other subtypes, how-
ever, indicates a particular sensitivity of this 
leukemia to compounds contained in paints 
and deserves further research, with greater 
attention to exposure assessment by obtain-
ing paint formulations from paint samples or 
manufacturers.
The possible influence of recall bias on the 
study results is probably the most important 
concern because differential recall between 
cases and controls can overestimate (or under-
estimate) an association in case–control design. 
Cases (or case parents) may have a tendency to 
better recall past exposures than do controls in 
an effort to elucidate what caused the disease 
Table 4. ORs (95% CIs) of ALL for household use of paint and solvents by cytogenetic subtype (conditional 
logistic regressions, adjustment for income, and either paint or solvent exposure).
  Paint exposure  Petroleum solvent exposure
  No. of  No. of    No. of 
  case–control  discordant    discordant
Cytogenetic subtype  sets  pairs/triplets (%)  OR (95% CI)  pairs/triplets (%)  OR (95% CI)
“Normal” karyotype  85  38 (44.7)  1.78 (0.87–3.64)  39 (45.9)  0.87 (0.43–1.76)
Abnormal karyotype  309  166 (53.7)  1.61 (1.13–2.30)  152 (49.2)  1.07 (0.74–1.53)
  Any structural change  190  105 (55.3)  1.96 (1.24–3.10)  102 (53.7)  0.86 (0.54–1.34)
  t(12;21)  67  38 (56.7)  4.16 (1.66–10.4)  39 (58.2)  0.98 (0.45–2.15)
  Any deletion  45  21 (46.7)  0.98 (0.39–2.49)  22 (48.9)  0.74 (0.30–1.81)
  Other structural change  83  47 (56.6)  1.63 (0.81–3.26)  43 (51.8)  0.84 (0.41–1.72)
  Any numerical change  227  124 (54.6)  1.48 (0.99–2.21)  108 (47.6)  1.05 (0.69–1.61)
  Hyperploidy (including triploidy)  186  103 (55.4)  1.42 (0.92–2.19)  85 (45.7)  1.18 (0.74–1.89)
  Hypodiploidy  24  15 (62.5)  2.18 (0.47–9.99)  14 (58.3)  0.62 (0.13–2.87)
Table 5. ORs (95% CIs) of AML for household use of paint and solvents for various users and time windows 
of use (conditional logistic regressions, adjustment for income, and either paint or solvent exposure).
Exposure  No. of discordant pairs/triplets (%)  OR (95% CI)
Paint
  Overall  52 (52.0)  0.64 (0.32–1.25)
  By period of exposure
  Preconception  20 (20.0)  1.35 (0.40–4.57)
  Pregnancy  32 (32.0)  0.99 (0.37–2.62)
  After birth  47 (47.0)  0.86 (0.41–1.77)
  By user   
  Mother  37 (37.0)  1.37 (0.61–3.11)
  Father  43 (43.0)  0.39 (0.17–0.92)
  Others  27 (27.0)  0.82 (0.33–2.06)
  Frequency of usea 
  Rarely  26 (26.0)  0.44 (0.18–1.07)
  Frequently  33 (33.0)  1.37 (0.59–3.16)
Solvents
  Overall  44 (44.0)  2.54 (1.19–5.42)
  By period of exposure 
  Before birth  42 (42.0)  0.87 (0.33–2.32)
  After birth  36 (36.0)  2.13 (0.77–5.86)
  By user   
  Mother  23 (23.0)  1.64 (0.58–4.62)
  Father  37 (37.0)  1.94 (0.87–4.32)
  Others  10 (10.0)  1.04 (0.23–4.64)
  Frequency of useb
  Rarely  15 (15.0)  4.24 (1.24–14.5)
  Frequently  35 (35.0)  2.23 (1.01–4.93)
a“Rarely” indicates one time window only (preconception, first, second, and third trimester of pregnancy, first, second, 
and third year of life) and fewer than five times; “Frequently” indicates other combinations. b“Rarely” indicates four time 
windows or fewer (preconception, first, second, and third trimester of pregnancy, first, second, and third year of life), and 
fewer than five times in each; “Frequently” indicates other combinations.
Table 6. ORs (95% CIs) of AML for household use of paint and solvents by cytogenetic subtype (conditional 
logistic regressions, adjustment for income, and either paint or solvent exposure).
  Paint exposure  Petroleum solvent exposure
  No. of  No. of    No. of
  case–control  discordant    discordant
Cytogenetic subtype  sets  pairs/triplets (%)  OR (95% CI)  pairs/triplets (%)  OR (95% CI)
“Normal” karyotype  16  10 (62.5)  0.25 (0.04–1.42)  9 (56.2)  1.05 (0.11–10.4)
Abnormal karyotype  65  30 (46.1)  0.86 (0.37–2.01)  28 (43.1)  2.12 (0.87–5.18)
  Any structural change  59  26 (44.1)  0.96 (0.39–2.35)  24 (40.7)  2.50 (0.96–6.54)
  Good prognosis groupa  28  15 (53.6)  0.70 (0.22–2.27)  13 (46.4)  3.49 (0.92–13.2)
  Other  31  11 (35.5)  2.00 (0.38–10.5)  11 (35.5)  1.09 (0.22–5.39)
  Any numerical change  35  14 (40.0)  1.62 (0.43–6.18)  14 (40.0)  0.78 (0.21–2.85)
aIncludes any translocation involving chromosome 21, t(15;17), t(8;16), and inv(16).Scélo et al.
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their child has experienced. Although recall 
bias cannot be totally excluded, to minimize 
the use of open-ended questions and reduce 
the potential for recall bias, our questionnaire 
listed a range of products that we subsequently 
grouped into paint and petroleum solvent 
exposures, and parents were shown cards 
that illustrated the potentially exposed time 
windows. Also, if recall bias were to entirely 
explain our results, we would expect similar 
associations for ALL and AML; instead, we 
found distinct results (ALL being associated 
with paint, whereas AML was associated with 
solvent exposures). Participating controls who 
might not be representative of the general 
population where cases occurred is another 
important issue that might bias an association 
(selection bias). In our study, for example, par-
ticipating controls had a higher annual income 
than did cases; socioeconomic status has been 
associated with the risk of childhood leukemia 
(Poole et al. 2006), and income was associated 
in our study with the use of paint and solvent 
at home. However, we adjusted all results for 
income and, if any effect remained, the higher 
proportion of high-income households among 
controls would have underestimated the risk 
estimates. Moreover, earlier analyses within 
our research group comparing several control 
groups demonstrated that the potential for 
selection bias in our study was minimal (Ma 
et al. 2004).
We evaluated potential confounders, such 
as parental smoking, breast-feeding, and par-
ents’ ages, education level, and occupational 
exposure to paint and solvents, and none sig-
nificantly influenced the risk estimates. We 
minimized confounding influences due to sex, 
age, and ethnicity by the matched-pair design. 
Because we individually matched the cases and 
controls, we maintained this control of poten-
tial confounders in the analysis by leukemia 
subtype. However, this approach cannot totally 
rule out potential confounding issues: Some 
confounders may have not been measured or 
may be too highly correlated with the exposure 
of interest. In our analyses of AML, adjusting 
solvent results for paint led to a higher OR 
(2.54 vs. 2.05 without adjustment) and adjust-
ing paint results for solvents decreased the OR 
already below the unity (0.64 vs. 0.91). This 
might reflect differences in type of products 
used (e.g., if paint was used whereas no solvent 
was used, paint was likely to be water based) 
and could lead to spurious results after adjust-
ment for the other exposure, especially when 
analyses are based on small numbers. The statis-
tically significant lower risk of AML associated 
with use of paint by the father (after adjusting 
for income and solvent) is particularly difficult 
to interpret because we would expect no asso-
ciation or an increased risk. However, adjusting 
for income only led to a nonsignificant OR of 
0.63 (95% CI, 0.30–1.32).
Lowengart et al. (1987) reported a statisti-
cally significant association between child-
hood leukemia (all types) and maternal use of 
paint during pregnancy (OR = 1.8, p = 0.03) 
based on 42 discordant case–control pairs, but 
attributed their results to chance because fre-
quent users exhibited a lower and nonsignifi-
cant OR (OR = 1.3, p = 0.30, based on seven 
discordant pairs). However, Freedman et al. 
(2001) reported a significant dose–response 
relationship between the risk of ALL and the 
number of rooms painted in the house in 
the year preceding and after the child’s birth. 
When stratifying the analyses by time win-
dow of exposure, they observed a significant 
association only when paint was used after the 
child’s birth. We observed an association with 
the risk of ALL both during pregnancy and 
postnatally and further detailed the associa-
tion by type of user. Analyzing all age groups 
together, the increased risk was statistically 
significant when paint was used by the father 
(OR = 1.44; 95% CI, 1.08–1.91) and by per-
sons other than the parents (OR = 1.63; 95% 
CI, 1.17–2.26). The type of user may be cor-
related with quantity of paint used. Persons 
other than father and mother using paint in 
the house were likely to be professional paint-
ers or relatives who would help repaint rooms. 
In addition, parents might have used paint 
more frequently for hobbies in decreased 
quantities. Our data showed that the time 
window of exposure had some influence on 
the risk estimate, which was statistically sig-
nificant when paint had been used after the 
child’s birth (OR = 1.39; 95% CI, 1.07–1.81) 
but not during pregnancy or in the precon-
ception period. However, when examining 
the results in the 0- to 1.9-year age group, the 
OR was higher when paint had been used by 
the mother (OR = 2.49; 95% CI, 0.92–6.78) 
during preconception (OR = 2.91; 95% CI, 
0.48–17.6) or pregnancy (OR = 1.92; 95% 
CI, 0.69–5.39). In the 2.0- to 5.9-year age 
group (which consists mainly of common 
ALL cases), results were comparable with the 
overall results, whereas in the older age group 
(≥ 6 years), risk estimates were closer to unity 
and not statistically significant. In the two 
younger age groups, ORs were higher for fre-
quent users compared with rare users of paint 
(ptrend = 0.031 and 0.010 in the 0- to 1.9-year 
and 2.0- to 5.9-year age groups, respectively). 
Although these subgroup analyses suffer from 
low statistical power, they tend to show that 
time since exposure has a higher impact on 
risk estimates than specific time window of 
exposure or type of user. Our results suggest 
that paint exposure would have a rather proxi-
mate effect on the risk of ALL in offspring. 
This hypothesis would explain the lack of 
association in the 6.0- to 14.9-year age group, 
because we measured exposures only until age 
3. On the other hand, leukemia occurring 
later in childhood has distinct clinical char-
acteristics and possibly a different etiology. 
Adolescent ALL cases start to resemble adult 
ALL cases and do not usually have t(12;21); 
the lack of association between paint exposure 
and older ALL cases would then be consistent 
with the specificity toward cases with t(12;21). 
However, because reported paint exposures 
between birth and 3 years of age happened 
longer ago than for younger children, misclas-
sification bias might be more important in 
older children and might partly explain the 
lack of association in this age group.
We detected the association between ALL 
risk and solvent exposure only in the 2.0- to 
5.9-year age group after adjustment for paint 
(OR = 1.55; 95% CI, 1.07–2.25). We found 
no difference in risk estimates between time 
windows of use or users. False-positive results 
or unmeasured confounding factors cannot 
be excluded as possible explanations of the 
observed association with solvents in the 2.0- 
to 5.9-year age group. We detected no dose–
response relationship, although frequency 
of use was more difficult to categorize than 
for paint because > 50% of households in 
our population that used solvents had used 
them in at least four time windows, and this 
regular use made classifications of “rare” and 
“frequent” users somewhat arbitrary. Also, 
the category of petroleum solvents consisted 
of a very broad and heterogeneous group of 
products, and errors in exposure classification 
might have biased risk estimates toward unity.
Because of the striking differences in the 
ORs for ALL risk between exposure to paint 
and to solvents, it is unlikely that the asso-
ciation observed with paint exposure is attrib-
utable to solvents contained in the paints. 
Household use of paint mainly involves latex 
paints, which typically contain vinyl acetate 
resin (polyvinyl acetate) or styrene-based resin 
(Kirk-Othmer 2006). Epidemiologic data and 
animal studies on polyvinyl acetate are too 
limited to allow evaluation of its potential car-
cinogenic risks in human beings, although 
further studies on this compound would be 
warranted when one considers that it has 
substantial commercial application (IARC 
Monograph Working Group 1979). On the 
other hand, styrene has been classified as possi-
bly carcinogenic to human, and several studies 
have reported increased risks of lymphatic and 
hematopoietic neoplasms in workers exposed 
to this product (IARC Monograph Working 
Group 2002), which makes styrene a putative 
candidate to explain the association between 
paint exposure and ALL risk.
The association found between AML 
risk and petroleum solvent exposure was less 
consistent than between ALL risk and paint 
exposure. Obviously, the lower numbers of 
subjects in the AML group make these analyses 
more prone to false-positive and false-negative Paint, solvents, and the risk of childhood leukemia
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results. The overall risk estimate was large (OR 
= 2.54; 95% CI, 1.19–5.42), but we observed 
no dose-dependent pattern, with higher but 
unstable risk estimate in “rare” users than in 
“frequent” users (OR = 4.24; 95% CI, 1.24–
14.5). However, our index of quantity of expo-
sure might not be well suited to our population 
who reported using solvents regularly. The 
measurement of petroleum solvent exposures 
would benefit from more detail in the type of 
products used, and the resulting measurement 
error may have diluted our results. On the 
other hand, the analyses by cytogenetic subtype 
showed a higher OR in the favorable prognosis 
group of AML (OR = 3.49; 95% CI, 0.92–
13.2), which is consistent with the chromo-
some banding patterns found in bone marrow 
cells of adult cases of AML that were exposed 
to solvents (Mitelman et al. 1981; Smith et al. 
1998). Interestingly, one previous study focus-
ing on childhood AML and its association with 
solvent exposure found a statistically significant 
association with paternal occupation exposure 
to petroleum solvents (Buckley et al. 1989).
In conclusion, our study corroborates ear-
lier findings on the association between paint 
exposure at home and ALL risk in childhood 
and provides further evidence supportive of a 
causal relationship, such as the restriction of 
the association to cases with specific cytoge-
netic features and a higher OR among more 
frequent users. Although paint may consist of 
various compositions, unless specific causative 
agents are identified, avoiding the use of paint 
in the house during pregnancy and early child-
hood would be a prudent measure. An associa-
tion between ALL risk and petroleum solvent 
exposure was suggested in the 2.0- to 5.9-year 
age group, although we observed no evidence 
of a dose–response relationship. AML risk was 
associated with petroleum solvent exposure, 
but smaller numbers complicated the interpre-
tation of detailed analyses and more studies are 
needed to confirm these observations.
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